KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

Protein Intake in Hemodialysis Patients Should Be Higher Than 1.2 g/kg/day: Commentary

Kopple JD. Protein Intake in Hemodialysis Patients Should Be Higher Than 1.2 g/kg/day: Commentary. Kidney360. 2025 Aug 19. doi: 10.34067/KID.0000000968. Epub ahead of print. PMID:[...]

Kidney transplantation between identical twins with APOL1 homozygote risk alleles – a case report

Lei S, Shankar A, Sethi S, Lum EL. Kidney transplantation between identical twins with APOL1 homozygote risk alleles - a case report. Front Nephrol. 2025[...]

dd-cfDNA Significantly Improves Rejection Yield in Kidney Transplant Biopsies

Bromberg JS, Brennan DC, Taber DJ, Cooper M, Anand S, Akalin E, Huang E, Klein JA, Glehn-Ponsirenas R, Rogers J, Chuang P, Kothari AS, Shen[...]